Pharma market in good health; lifestyle diseases may be rising

The other leading molecules in the same segment, like rosuvastatin and telmisartan, continued to grow in line with the therapy segment, the data showed. According to Pharmarack, emerging molecules like vericiguat, finerenone and midodrine also posted robust growth.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/vsrhiJD
via IFTTT